Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.32 0.00 (-0.65%)
At close: Oct 2, 2026 · 4:00 PM EDT

Senti Biosciences Holdings (SNTI) Depreciation & Amortization (CF) (2021 - 2025)

Updated

Senti Biosciences Holdings (SNTI) posted Depreciation & Amortization (CF) of $893,000 for Q4 2025, down 4.7% from $937,000 a year earlier and down 1.2% from the prior quarter.

Analysis

Senti Biosciences Holdings (SNTI) Depreciation & Amortization (CF) (2021 - 2025) Analysis & Trends

For FY2025, Senti Biosciences Holdings' Depreciation & Amortization (CF) came in at $3.64 million, down 5.2% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a four-year compound annual growth rate of 46.0% (FY2021 to FY2025).
  • In prior years, Senti Biosciences Holdings' Depreciation & Amortization (CF) was $3.84 million in FY2024 (+7.8%), $3.56 million in FY2023 (+154.7%), $1.4 million in FY2022 (+74.8%) and $800,000 in FY2021.
  • The Q4 2025 figure stands as the lowest quarterly Depreciation & Amortization (CF) since Q2 2023.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last six quarters, with growth averaging 9.5% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2023, with growth of 237.0%; the weakest was Q3 2024, with a decline of 29.8%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $904,000 (Q3 2025), $914,000 (Q2 2025) and $926,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Senti Biosciences Holdings 9.65 Mn 9.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 893,000.00
Sep 30, 2025 904,000.00
Jun 30, 2025 914,000.00
Mar 31, 2025 926,000.00
Dec 31, 2024 937,000.00
Sep 30, 2024 946,000.00
Jun 30, 2024 971,000.00
Mar 31, 2024 984,000.00
Dec 31, 2023 992,000.00
Sep 30, 2023 1.35 Mn
Jun 30, 2023 800,000.00
Mar 31, 2023 467,000.00
Dec 31, 2022 452,000.00
Sep 30, 2022 400,000.00
Jun 30, 2022 300,000.00
Mar 31, 2022 240,000.00
Dec 31, 2021 257,000.00
Sep 30, 2021 200,000.00
Jun 30, 2021 200,000.00
API Access

Senti Biosciences Holdings Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SNTI&period=max&api_key=YOUR_API_KEY